Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00618033 · ClinicalTrials.gov registry record · NA

Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients

A NA study of ESRD and Hemodialysis, sponsored by Renal Research Institute.

Completed
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT00618033 is a NA study of ESRD and Hemodialysis that has completed, run by Renal Research Institute. The registered enrollment target is 30 participants, below the 138-participant average among 13 other ESRD trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00618033, a NA study of ESRD and Hemodialysis, has completed, sponsored by Renal Research Institute.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with regard to the frequency and magnitude of blood glucose drops. Other parameters that will be compared between the two groups are blood pressure, heart rhythm, weight gain between dialysis treatments, and fatigue after the treatment.

Conditions Studied

ESRD Hemodialysis

Interventions

  • PROCEDURE Hemodialysis

Study Locations (2)

New York

  • Irving Place Dialysis Center - New York
  • Yorkville Dialysis Center - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-02
Est. Completion 2008-08
Phase NA

Sponsor

Renal Research Institute

14 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00618033

The ClinicalTrials.gov registry entry for NCT00618033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 13 other ESRD trials with a reported enrollment target (78% lower). The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ESRD appearing as the primary indexed condition, and to 1 intervention - of which Hemodialysis is the first listed.

NCT00618033 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00618033 about?

NCT00618033 is a clinical study titled "Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients". This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with regard to the frequency and magnitude of blood glucose drops. Other parameters that will be compared between the two group...

What is the current status of trial NCT00618033?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2008-08.

What conditions does trial NCT00618033 study?

This clinical trial studies the following conditions: ESRD, Hemodialysis.

What interventions are being tested in trial NCT00618033?

The interventions under investigation include: Hemodialysis (PROCEDURE).

Who is sponsoring clinical trial NCT00618033?

This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00618033 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for ESRD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

ESRD

All registered trials for this condition

Hemodialysis

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.